scholarly journals 3D convolutional neural networks-based multiclass classification of Alzheimer’s and Parkinson’s diseases using PET and SPECT neuroimaging modalities

2021 ◽  
Vol 8 (1) ◽  
Author(s):  
Ahsan Bin Tufail ◽  
Yong-Kui Ma ◽  
Qiu-Na Zhang ◽  
Adil Khan ◽  
Lei Zhao ◽  
...  

Abstract Background Alzheimer’s disease (AD) is a neurodegenerative brain pathology formed due to piling up of amyloid proteins, development of plaques and disappearance of neurons. Another common subtype of dementia like AD, Parkinson’s disease (PD) is determined by the disappearance of dopaminergic neurons in the region known as substantia nigra pars compacta located in the midbrain. Both AD and PD target aged population worldwide forming a major chunk of healthcare costs. Hence, there is a need for methods that help in the early diagnosis of these diseases. PD subjects especially those who have confirmed postmortem plaque are a strong candidate for a second AD diagnosis. Modalities such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) can be combined with deep learning methods to diagnose these two diseases for the benefit of clinicians. Result In this work, we deployed a 3D Convolutional Neural Network (CNN) to extract features for multiclass classification of both AD and PD in the frequency and spatial domains using PET and SPECT neuroimaging modalities to differentiate between AD, PD and Normal Control (NC) classes. Discrete Cosine Transform has been deployed as a frequency domain learning method along with random weak Gaussian blurring and random zooming in/out augmentation methods in both frequency and spatial domains. To select the hyperparameters of the 3D-CNN model, we deployed both 5- and 10-fold cross-validation (CV) approaches. The best performing model was found to be AD/NC(SPECT)/PD classification with random weak Gaussian blurred augmentation in the spatial domain using fivefold CV approach while the worst performing model happens to be AD/NC(PET)/PD classification without augmentation in the frequency domain using tenfold CV approach. We also found that spatial domain methods tend to perform better than their frequency domain counterparts. Conclusion The proposed model provides a good performance in discriminating AD and PD subjects due to minimal correlation between these two dementia types on the clinicopathological continuum between AD and PD subjects from a neuroimaging perspective.

Author(s):  
Ilker Ozsahin ◽  
Boran Sekeroglu ◽  
Pwadubashiyi Coston Pwavodi ◽  
Greta S.P. Mok

Purpose: Parkinson's disease (PD), which is the second most common neurodegenerative disease following Alzheimer’s disease, can be diagnosed clinically when about 70% of the dopaminergic neurons are lost and symptoms are noticed. Neuroimaging methods such as single photon emission computed tomography have become useful tools in vivo to assess dopamine transporters (DATs) in the striatal region. However, inter- and intra-reader variability of construing the images might result in misdiagnosis. To overcome the challenges posed by classification of the disease, image preparation techniques and a back propagation neural network (BPNN) have been proposed. The aim of this study is to show that the proposed method can be used for the classification of PD with high accuracy. Methods: In this study, we used basic image preparation techniques and a BPNN on DAT imaging datasets from the Parkinson’s Progression Markers Initiative. 1,334 PD and 212 normal control (NC) subjects were included. In the image preparation phase, adaptive histogram equalization was applied to the cropped images, followed by image binarization. Then, the mass-difference method was applied to separate the regions of interest with similar values. Finally, the binarized images were subtracted from the original images, and the average pixel per node approach was applied to the images to minimize the inputs. In the BPNN phase, 400 input neurons and 2 output neurons were used. The dataset was divided into three sets: training, validation, and test. The BPNN was trained several times in order to obtain the optimum values. Results: The use of 40 hidden neurons, a learning rate of 0.00079, and a momentum factor of 0.90 produced superior results and were applied in the final BPNN architecture. The tolerance value used was 0.80. Uniquely, we found the sensitivity, specificity, and accuracy for PD vs. NC classification to be 99.7%, 99.2%, 99.6%, respectively. To the best of our knowledge, this is the highest accuracy value achieved in the existing literature. Our method increases computational speed together with improved performance. Conclusion: We have shown that effective image processing methods and the use of BPNN can successfully be applied to PD datasets to accurately determine any abnormalities in DATs. Using the shallow neural network, this procedure requires less processing time compared to other methods, and its accuracy, sensitivity, and specificity are reliable. However, further studies are needed to establish a prediction method for the preclinical and prodromal stages of the disease.


Author(s):  
Binny Naik ◽  
Ashir Mehta ◽  
Manan Shah

Abstract Alzheimer’s disease (AD) is the most common type of dementia. The exact cause and treatment of the disease are still unknown. Different neuroimaging modalities, such as magnetic resonance imaging (MRI), positron emission tomography, and single-photon emission computed tomography, have played a significant role in the study of AD. However, the effective diagnosis of AD, as well as mild cognitive impairment (MCI), has recently drawn large attention. Various technological advancements, such as robots, global positioning system technology, sensors, and machine learning (ML) algorithms, have helped improve the diagnostic process of AD. This study aimed to determine the influence of implementing different ML classifiers in MRI and analyze the use of support vector machines with various multimodal scans for classifying patients with AD/MCI and healthy controls. Conclusions have been drawn in terms of employing different classifier techniques and presenting the optimal multimodal paradigm for the classification of AD.


Molecules ◽  
2020 ◽  
Vol 25 (20) ◽  
pp. 4792
Author(s):  
Shih-Yen Hsu ◽  
Li-Ren Yeh ◽  
Tai-Been Chen ◽  
Wei-Chang Du ◽  
Yung-Hui Huang ◽  
...  

Single photon emission computed tomography (SPECT) has been employed to detect Parkinson’s disease (PD). However, analysis of the SPECT PD images was mostly based on the region of interest (ROI) approach. Due to limited size of the ROI, especially in the multi-stage classification of PD, this study utilizes deep learning methods to establish a multiple stages classification model of PD. In the retrospective study, the 99mTc-TRODAT-1 was used for brain SPECT imaging. A total of 202 cases were collected, and five slices were selected for analysis from each subject. The total number of images was thus 1010. According to the Hoehn and Yahr Scale standards, all the cases were divided into healthy, early, middle, late four stages, and HYS I~V six stages. Deep learning is compared with five convolutional neural networks (CNNs). The input images included grayscale and pseudo color of two types. The training and validation sets were 70% and 30%. The accuracy, recall, precision, F-score, and Kappa values were used to evaluate the models’ performance. The best accuracy of the models based on grayscale and color images in four and six stages were 0.83 (AlexNet), 0.85 (VGG), 0.78 (DenseNet) and 0.78 (DenseNet).


Sign in / Sign up

Export Citation Format

Share Document